A detailed history of Rafferty Asset Management, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 93,456 shares of MYGN stock, worth $2.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
93,456
Previous 249,203 62.5%
Holding current value
$2.05 Million
Previous $5.31 Million 56.99%
% of portfolio
0.01%
Previous 0.02%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$17.98 - $25.47 $2.8 Million - $3.97 Million
-155,747 Reduced 62.5%
93,456 $2.29 Million
Q1 2024

May 13, 2024

BUY
$17.59 - $23.59 $1.37 Million - $1.84 Million
77,804 Added 45.39%
249,203 $5.31 Million
Q4 2023

Feb 13, 2024

SELL
$13.91 - $21.32 $515,852 - $790,652
-37,085 Reduced 17.79%
171,399 $3.28 Million
Q3 2023

Nov 13, 2023

BUY
$15.99 - $23.22 $195,589 - $284,027
12,232 Added 6.23%
208,484 $3.34 Million
Q2 2023

Aug 11, 2023

BUY
$17.56 - $23.76 $463,777 - $627,525
26,411 Added 15.55%
196,252 $4.55 Million
Q1 2023

May 11, 2023

SELL
$15.26 - $23.75 $556,867 - $866,685
-36,492 Reduced 17.69%
169,841 $3.95 Million
Q4 2022

Feb 13, 2023

BUY
$14.51 - $20.99 $508,560 - $735,678
35,049 Added 20.46%
206,333 $2.99 Million
Q3 2022

Nov 14, 2022

BUY
$18.21 - $27.88 $1.14 Million - $1.74 Million
62,482 Added 57.43%
171,284 $3.27 Million
Q2 2022

Aug 12, 2022

SELL
$16.45 - $25.88 $364,943 - $574,147
-22,185 Reduced 16.94%
108,802 $1.98 Million
Q1 2022

May 13, 2022

SELL
$22.67 - $28.01 $1.04 Million - $1.29 Million
-45,935 Reduced 25.96%
130,987 $3.3 Million
Q4 2021

Feb 10, 2022

BUY
$24.13 - $32.63 $2.01 Million - $2.71 Million
83,152 Added 88.68%
176,922 $4.88 Million
Q3 2021

Nov 10, 2021

BUY
$29.97 - $36.66 $180,779 - $221,133
6,032 Added 6.88%
93,770 $3.03 Million
Q2 2021

Aug 10, 2021

SELL
$25.39 - $32.61 $497,999 - $639,612
-19,614 Reduced 18.27%
87,738 $2.68 Million
Q1 2021

May 10, 2021

BUY
$19.92 - $31.6 $1.73 Million - $2.75 Million
86,871 Added 424.15%
107,352 $3.27 Million
Q4 2020

Feb 10, 2021

SELL
$12.16 - $19.77 $730,414 - $1.19 Million
-60,067 Reduced 74.57%
20,481 $405,000
Q3 2020

Nov 13, 2020

BUY
$11.25 - $14.75 $309,487 - $405,772
27,510 Added 51.87%
80,548 $1.05 Million
Q2 2020

Aug 07, 2020

BUY
$10.69 - $16.49 $459,028 - $708,080
42,940 Added 425.23%
53,038 $601,000
Q1 2020

May 15, 2020

SELL
$9.78 - $29.53 $739,945 - $2.23 Million
-75,659 Reduced 88.22%
10,098 $145,000
Q4 2019

Feb 10, 2020

SELL
$20.93 - $35.1 $1.17 Million - $1.97 Million
-56,088 Reduced 39.54%
85,757 $2.34 Million
Q3 2019

Nov 14, 2019

SELL
$22.08 - $47.08 $598,522 - $1.28 Million
-27,107 Reduced 16.04%
141,845 $4.06 Million
Q2 2019

Aug 09, 2019

BUY
$22.67 - $35.0 $504,679 - $779,170
22,262 Added 15.18%
168,952 $4.69 Million
Q1 2019

May 15, 2019

BUY
$26.93 - $34.7 $3.95 Million - $5.09 Million
146,690 New
146,690 $4.87 Million
Q4 2018

Feb 11, 2019

SELL
$27.23 - $45.56 $477,015 - $798,120
-17,518 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$37.57 - $50.34 $658,151 - $881,856
17,518 New
17,518 $806,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.